HSP90AA1 and hepatocellular carcinoma: In addition, the combination of HSP90α and AFP significantly improved the diagnostic ability of HCC from healthy donors (AUC 0.943, sensitivity 85.89%, specificity 98.26%, Fig.3a, Table 2).